Frontlight ResearchEarly access
Trial site
UCSF Investigational Drugs Pharmacy
- 3running trials
- 1closed trial
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Bladder cancer2 trials
- Gastric and oesophageal cancer1 trial
- Metastatic breast cancer1 trial
- Ovarian cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 1/21 trial
- Phase 21 trial
- Phase 2/31 trial
- Phase 31 trial
- Status
- Active, not recruiting1 trial
- Not yet recruiting1 trial
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Pfizer2 trials
- Seagen, a wholly owned subsidiary of Pfizer2 trials
Running trials
Recruiting
Active, not recruiting
Recruiting
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bladder cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026